||Registry of biomedical companies:
  [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 465 active entries
3815 Technology Blvd
Lansing, MI 48909-0609 USA
United States of America, Michigan
Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.
Founded in 1981, MBI (Michigan Biotechnology Institute) is both a premier multidisciplinary center sought out by industry partners for unique derisking capabilities and a 501(c)(3) not-for-profit inspired by a mission to enhance quality of life by collaboratively accelerating the commercialization of sustainable biobased technologies.
MBI is known in the industrial biotechnology field for pioneering derisking, a process that quickly and cost-effectively weeds out flawed technologies and accelerates viable ones through a milestone-based, stage-gated innovation process. Highly seasoned team members roadmap, prioritize, and address technical and commercial risks to effectively and efficiently accelerate early-stage technologies to market-readiness.
MBI applies this derisking approach to the development of biofuels, chemicals, food and feed from renewable, rather than fossil, raw materials. We engage with universities, corporations and research institutions—and our long list of collaborators includes DuPont, Genomatica, Bolt Threads, Novozymes, NatureWorks, OPX, Tepha Medical Devices, Verdezyne, and the Great Lakes Bioenergy Research Center.
Last update of this entry: August 25, 2015